Page 60 - MemoriaCIBER2019-ESP

60
CIBER Memoria anual 2019
10 publicaciones más relevantes según factor de impacto
FI Publicación 36,216
25,455
25,455 24,54 23,53
17,161
15,621
15,27
15,27
15,27
hernandez-alvarez M.i., sebasTian d., vives s., ivanova s., barToccioni P., kakiMoTo P. eT al. Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell. 2019;177(4):881-895. e17.
MiGUel-escalada i., bonas-GUarch s., cebola i., Ponsa-cobas j., MendieTa-esTeban j., aTla G. eT al. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nature Genetics. 2019;51(7):1137-1148.
raMos-rodriGUez M., raUrell-vila h., colli M.l., alvelos M.i., sUbirana-Granes M., jUan-MaTeU j. eT al. The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nature Genetics. 2019;51(11):1588-1595.
ibanez l., de zeGher F. Exploring the use of metformin in pregnant women with polycystic ovary syndrome: new evidence, new wisdom. The Lancet Diabetes and Endocrinology. 2019;7(4):242-243.
keiran n., cePerUelo-MallaFre v., calvo e., hernandez-alvarez M.i., ejarqUe M., nUnez-roa c. eT al. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity. Nature Immunology. 2019;20(5):581-592.
FiGUeiredo h., FiGUeroa a.l.c., Garcia a., Fernandez-rUiz r., broca c., WojTUsciszyn a. eT al. Targeting pancreatic islet PTP1B improves islet graft revascularization and transplant outcomes. Science Translational Medicine. 2019;11(497): eaar6294.
iakab s.a., raFols P., Garcia-alTares M., yanes o., correiG X. Silicon-Based Laser Desorption Ionization Mass Spectrometry for the Analysis of Biomolecules: A Progress Report. Advanced Functional Materials. 2019;29(45):1903609.
ceriello a., rossi M.c., de cosMo s., lUcisano G., PonTreMoli r., FioreTTo P. eT al. Overall quality of care predicts the variability of key risk factors for complications in type 2 diabetes: An observational, longitudinal retrospective study. Diabetes Care. 2019;42(4):514-519.
GUTierrez-carrasqUilla l., sanchez e., barbe F., dalMases M., loPez-cano c., hernandez M. eT al. Effect of glucose improvement on spirometric maneuvers in patients with type 2 diabetes: The Sweet breath study. Diabetes Care. 2019;42(4):617-624.
rodbard hW, rosensTock j, canani lh, deerochanaWonG c, GUMPrechT j, lindberG so, eT al. Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: The PIONEER 2 trial. Diabetes Care. 2019;42(12):2272-2281.